Article Information
- Received September 19, 2013
- Revision received January 15, 2014
- Accepted February 4, 2014
- First published March 12, 2014.
- Version of record published March 12, 2014.
Author Information
- 1Mitchell Center for Neurodegenerative Diseases,
- 2Departments of Neurology and
- 3Internal Medicine, Division of Endocrinology,
- 4McCoy Stem Cells and Diabetes Mass Spectrometry Research Laboratory,
- 5Sealy Center for Molecular Medicine, and
- 6Institute for Translational Science, University of Texas Medical Branch, Galveston, Texas 77555
Author contributions
Author contributions: J.B.J., C.M.H., L.D., and K.T.D. designed research; J.B.J. and C.M.H. performed research; J.B.J. and K.T.D. analyzed data; J.B.J., L.D., and K.T.D. wrote the paper.
Disclosures
- Received September 19, 2013.
- Revision received January 15, 2014.
- Accepted February 4, 2014.
This work was supported by the National Institutes of Health under Grant R01-AG031859 (to K.T.D. and L.D.). Additional funding was provided by the American Health Assistance Foundation, The Sealy Foundation for Biomedical Research, and a gift from J.W. Mohn (to K.T.D. and L.D.); by the Emmett and Miriam McCoy Foundation (to L.D.); and by the Cullen Trust for Health Care to the Mitchell Center. Behavioral testing was performed in the University of Texas Medical Branch at Galveston Rodent In Vivo Assessment Core directed by K.T.D. We thank Drs. Nicole Bjorklund and Giulio Taglialatela for generously providing the human tissue samples investigated herein. We also thank Wei Song for expert technical assistance and Ibdanelo Cortez for a number of insightful discussions.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Kelly T. Dineley, 301 University Boulevard, Galveston TX 77555-0616. ktdinele{at}utmb.edu
Online Impact